Categories: News

Form 8.3 – Willis Towers Watson plc.

Form 8.3 – Willis Towers Watson plc.Form 8.3 – Willis Towers Watson plc.
FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

                FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1) State Street Global Advisors & Affiliates
Company dealt in Willis Towers Watson plc.
Class of relevant security to which
the dealings being disclosed relate (Note 2)		 US$0.000304635 ordinary shares
Date of dealing 06th January 2021
   
Read moreFossil launches its first smartwatch on the Qualcomm Snapdragon Wear 3100 platform

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

  Long Short
  Number (%) Number (%)
(1) Relevant securities 6,222,431

 

 

 

Read moreTorus and Aareon Collaborate on Housing Management Solution

 

 

 

 

 

Read moreConwy Care Home Multi-Professional Response wins Secure I.T. Environments Sponsored award at Betsi Cadwaladr University Health Board Achievement Awards

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 4.82713%

 

    
(2) Derivatives (other than options) N/A      
(3) Options and agreements to
purchase/sell		 N/A      
Total 6,222,431

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 4.82713%

 

    

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security: Long Short
  Number (%) Number (%)
(1) Relevant securities N/A      
(2) Derivatives (other than options) N/A      
(3) Options and agreements to purchase/sell N/A      
Total N/A      

3. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale Number of relevant securities Price per unit (Note 5)
Purchase 300 203.70
Purchase 7 203.70
Purchase 21 203.70
Purchase 9,652 203.70
Purchase 1,218 203.70
Purchase 59,624 203.70
Purchase 210 203.70
Purchase 680 203.70
Purchase 340 203.70
Purchase 4 203.70
Purchase 63 203.70
Purchase 100 203.70
Sale 100 203.70
Sale 200 203.70
Sale 100 203.70
Sale 41 203.70
Sale 6 203.70
Sale 256 203.70

 (b) Derivatives transactions (other than options transactions)

Product name,
e.g. CFD		 Nature of transaction

(Note 6)		 Number of relevant securities

(Note 7)		 Price per unit

(Note 5)
N/A      

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,
e.g. call option		 Writing, selling,
purchasing
 varying etc.		 Number of
securities to which
the option relates
(Note 7)		 Exercise
price		 Type, e.g.
American,
European etc.		 Expiry
date		 Option money
paid/received
per unit (Note 5)
N/A            

(ii) Exercising

Product name,
e.g. call option		 Number of securities Exercise price per
unit (Note 5)
N/A    

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction
(Note 8)		 Details Price per unit
(if applicable) (Note 5)
N/A    

4. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
N/A

Is a Supplemental Form 8 attached? (Note 9) NO

Date of disclosure 07th  January 2021

 
Contact name Lionel Colaco
Telephone number                                                             020 33956098
If a connected EFM, name of offeree/offeror with which connected N/A
If a connected EFM, state nature of connection (Note 10) N/A

Staff

Share
Published by
Staff
4 years ago

Recent Posts

Netsmart Showcases Meaningful AI and New Innovations of the CareFabric® Platform to Optimize Community-Based Care at NatCon25

OVERLAND PARK, Kan.--(BUSINESS WIRE)--#Acquisition--Netsmart, an industry-leading provider of healthcare IT for human services and post-acute…

2 hours ago

AV Laboratories Appoints Roula Youssef Halabi to Business Advisory Board to Expand Presence in UAE and Middle East

NEW YORK--(BUSINESS WIRE)--AV Laboratories, a leader in science-backed skincare and luxury skin longevity, proudly announces…

2 hours ago

Eight Student Teams Named National Winners of 33rd Annual ExploraVision Competition

Toshiba and the National Science Teaching Association (NSTA) honor student innovation with prizes and award…

2 hours ago

Psomagen Selected as Key Service Provider, Will Utilize Ultima Genomics’ UG 100™ Sequencer to Accelerate Chan Zuckerberg Initiative’s Billion Cells Project

ROCKVILLE, Md., May 5, 2025 /PRNewswire/ -- Psomagen Inc., a multiomics service laboratory serving academic,…

2 hours ago

Arctic Quest: 8,000-Mile Motorcycle Ride Honors Indigenous Women and Girls

Our Rescue, Mental Health Tech Company and First Nations Advocate Unite to Raise Awareness and…

2 hours ago

Digital Twins in Healthcare Market worth US$59.94 billion by 2030 with 68.0% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., May 5, 2025 /PRNewswire/ -- The global Digital Twins in Healthcare Market,…

2 hours ago